Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a ...

It did not have a significantly different therapeutic efficacy from the commercial paste dosage form in the treatment of oral lichen planus. Buffering agents and an antioxidant should be added to ...

Lichen planus often leaves a dark brown discolouration on the skin, which eventually fades away without any treatment. Patients with oral lichen planus are at a slightly greater risk for ...

Lipella Pharmaceuticals Inc. (LIPO), a clinical-stage biotechnology company, Wednesday said that the U.S. Food and Drug ...

Treatment: There is no cure for lichen planus ... One in five will have a recurrence of lichen planus. Oral lichen planus with ulceration must be followed meticulously to prevent the development ...

Lipella Pharma receives US FDA nod for expanded access programme for LP-310, an oral rinse formulation to treat oral lichen planus: Pittsburgh Saturday, February 8, 2025, 09:00 Hr ...

The FDA’s approval for expanded use reinforces LP-310’s potential as a new therapeutic option for OLP and supports ongoing clinical development efforts.

“Receiving FDA approval for expanded use of LP-310 represents a key milestone in our mission to address the significant unmet need in oral lichen planus treatment,” said Michael ...

PITTSBURGH - Lipella Pharmaceuticals Inc. (NASDAQ:LIPO), a biotech firm specializing in novel therapies for medical conditions lacking adequate treatments, has received FDA approval for an Expanded ...

Treatment will vary depending on the specific ... that can cause bumps and sores on the skin or in the mouth. Oral lichen planus can appear on the tongue. Oral lichen planus is a common ...

“Receiving FDA approval for expanded use of LP-310 represents a key milestone in our mission to address the significant unmet need in oral lichen planus treatment,” said Michael ...